88.5%
Glypican 3SALL4AFPhepatocellular carcinomaAFPGCTAEgastric carcinoma1
…well- to poorly differentiated adenocarcinoma (figure 3B). AFP, Glypican 3 and SALL4 were positive by immunohistochemical analysis (figure…
1articles mentioning drugs
1drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: Glypican 3 ×
Glypican 3
This drug is selected. Its supporting articles are shown below.